G. Ozkat And İ. YILDIZ, "In Silico Studies to Develop New GSK3 beta Inhibitors Effective in the 's Disease," LETTERS IN DRUG DESIGN & DISCOVERY , vol.19, no.8, pp.691-705, 2022
Ozkat, G. And YILDIZ, İ. 2022. In Silico Studies to Develop New GSK3 beta Inhibitors Effective in the 's Disease. LETTERS IN DRUG DESIGN & DISCOVERY , vol.19, no.8 , 691-705.
Ozkat, G., & YILDIZ, İ., (2022). In Silico Studies to Develop New GSK3 beta Inhibitors Effective in the 's Disease. LETTERS IN DRUG DESIGN & DISCOVERY , vol.19, no.8, 691-705.
Ozkat, GÖZDE, And İLKAY YILDIZ. "In Silico Studies to Develop New GSK3 beta Inhibitors Effective in the 's Disease," LETTERS IN DRUG DESIGN & DISCOVERY , vol.19, no.8, 691-705, 2022
Ozkat, GÖZDE Y. And YILDIZ, İLKAY. "In Silico Studies to Develop New GSK3 beta Inhibitors Effective in the 's Disease." LETTERS IN DRUG DESIGN & DISCOVERY , vol.19, no.8, pp.691-705, 2022
Ozkat, G. And YILDIZ, İ. (2022) . "In Silico Studies to Develop New GSK3 beta Inhibitors Effective in the 's Disease." LETTERS IN DRUG DESIGN & DISCOVERY , vol.19, no.8, pp.691-705.
@article{article, author={GÖZDE YALÇIN ÖZKAT And author={İLKAY YILDIZ}, title={In Silico Studies to Develop New GSK3 beta Inhibitors Effective in the 's Disease}, journal={LETTERS IN DRUG DESIGN & DISCOVERY}, year=2022, pages={691-705} }